Drugdiscovery >> Clinical Trials >> News
7546
Views
Mallinckrodt's pain drug successful in Phase 3 clinical trial - drugdiscovery.com
Mallinckrodt's pain drug successful in Phase 3 clinical trial - drugdiscovery.com


The experimental pain drug MNK-795 met the primary endpoint of a Phase 3 study, improving the pain scores, compared to placebo, in patients with acute pain after surgery.
Read More >>


Tags: pain drug, MNK-795, clinical trial, Mallinckrodt - September 8, 2013
Related Articles
7991
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

5757
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

12967
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

19791
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

7680
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

6818
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

7049
Views
Special Protocol Assessment  for a Phase 3 clinical trial of antibiotic plazomicin Special Protocol Assessment for a Phase 3 clinical trial of antibiotic plazomicin
Plazomicin is a next-generation aminoglycoside antibiotic engineered by Achaogen. It has potent bactericidal activity against important gram-negative pathogens, including carbapenem-resistant Enteroba Read More >>

Tags: plazomicin, antibiotic, aminoglycoside antibiotic, next generation, Achaogen, gram-negative, CRE, clinical trial, multi-drug resistant, MDR, bacterial infections

6877
Views
A global Phase 3 clinical trial for Alzheimer’s disease to be lounched A global Phase 3 clinical trial for Alzheimer’s disease to be lounched
Takeda and Zinfandel have announced the initiation of TOMMORROW Phase 3 clinical trial which will investigate a genetic-based biomarker risk assignment algorithm for the predicition of the risk of mil Read More >>

Tags: clinical trial, global, Alzheimer’s disease, Takeda, Zinfandel, risk assignment algorithm, cognitive impairment risk, pioglitazone, investigational drug

2849
Views
BMS diabetes drug successful in late-stage study BMS diabetes drug successful in late-stage study
Bristol-Myers Squibb has announced that its diabetes drug dapagliflozin, helped improve blood sugar levels and reduce body weight in patients with type 2 diabetes who were taking a combination of metf Read More >>

Tags: type 2 diabetes, Bristol-Myers Squibb, dapagliflozin, clinical trial, Forxiga

7104
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial
The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sug Read More >>

Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013